Active	Status	Sponsor type	Region	Phase	Filter
1 Active 217 Inactive 218 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Skin Manifestations
NCT01183988: Compassionate Use of Stannsoporfin in Addition to Phototherapy to Reduce the Need for Exchange Transfusions in Term and Near-Term Infants	Enrolling by invitation	N/A	50	NA	Stanate®	InfaCare Pharmaceuticals Corporation	Neonatal Hyperbilirubinemia, Neonatal Jaundice, Jaundice, Hyperbilirubinemia	10/13	10/13